{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:05:03Z","timestamp":1779800703720,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00105-026-05682-6","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:57:42Z","timestamp":1776113862000},"page":"397-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["M\u00f6glichkeiten der Therapie des berufsbedingten Hautkrebses (BK\u00a05102, BK\u00a05103)","Therapeutic options for occupational skin cancer (BK\u00a05102, BK\u00a05103)"],"prefix":"10.1007","volume":"77","author":[{"given":"Konstantin","family":"Drexler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"8","key":"5682_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S1470-2045(22)00347-3","volume":"23","author":"F Adan","year":"2022","unstructured":"Adan\u00a0F, Nelemans\u00a0PJ, Essers\u00a0BAB et\u00a0al (2022) Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trial. Lancet Oncol 23(8):1087\u20131096","journal-title":"Lancet Oncol"},{"key":"5682_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.116068","volume":"230","author":"J Balkenhol","year":"2025","unstructured":"Balkenhol\u00a0J, Dirschka\u00a0T, Falkenberg\u00a0C et\u00a0al (2025) Cutaneous squamous cell carcinoma 1986-2019 in Germany: Incidence, anatomical site, staging, and histologic subtypes. Eur J Cancer 230:116068","journal-title":"Eur J Cancer"},{"issue":"6","key":"5682_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1056\/NEJMoa2024040","volume":"384","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt\u00a0A, Kempers\u00a0S, Lain\u00a0E et\u00a0al (2021) Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis. N\u00a0Engl J Med 384(6):512\u2013520","journal-title":"N Engl J Med"},{"issue":"8","key":"5682_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","volume":"9","author":"KD Brantsch","year":"2008","unstructured":"Brantsch\u00a0KD, Meisner\u00a0C, Sch\u00f6nfisch\u00a0B et\u00a0al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9(8):713\u2013720","journal-title":"Lancet Oncol"},{"key":"5682_CR5","doi-asserted-by":"crossref","unstructured":"Chen OM, Kim K, Steele C et\u00a0al. (2022) Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. Cancers (Basel) 14(15)","DOI":"10.3390\/cancers14153720"},{"issue":"12","key":"5682_CR6","first-page":"1102","volume":"12","author":"TL Diepgen","year":"2014","unstructured":"Diepgen\u00a0TL, Brandenburg\u00a0S, Aberer\u00a0W et\u00a0al (2014) Skin cancer induced by natural UV-radiation as an occupational disease\u2014requirements for its notification and recognition. J\u00a0Dtsch Dermatol Ges 12(12):1102\u20131106","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"5682_CR7","first-page":"875","volume":"14","author":"TL Diepgen","year":"2016","unstructured":"Diepgen\u00a0TL (2016) New developments in occupational dermatology. J\u00a0Dtsch Dermatol Ges 14(9):875\u2013889","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"5682_CR8","first-page":"1218","volume":"15","author":"MA Dohil","year":"2016","unstructured":"Dohil\u00a0MA (2016) Efficacy, Safety, and Tolerability of 4\u202f% 5\u2011Fluorouracil Cream in a\u00a0Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5\u202f% 5\u2011Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis. J\u00a0Drugs Dermatol 15(10):1218\u20131224","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"5682_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/bjd\/ljad371","volume":"190","author":"CD George","year":"2024","unstructured":"George\u00a0CD, Lee\u00a0T, Hollestein\u00a0LM et\u00a0al (2024) Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis. Br J Dermatol 190(4):465\u2013476","journal-title":"Br J Dermatol"},{"key":"5682_CR10","doi-asserted-by":"crossref","unstructured":"Gust C, Schuh S, Welzel J et\u00a0al. (2022) Line-Field Confocal Optical Coherence Tomography Increases the Diagnostic Accuracy and Confidence for Basal Cell Carcinoma in Equivocal Lesions: A\u00a0Prospective Study. Cancers (Basel) 14(4)","DOI":"10.3390\/cancers14041082"},{"issue":"5","key":"5682_CR11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1365-2133.2009.09040.x","volume":"160","author":"A Hauschild","year":"2009","unstructured":"Hauschild\u00a0A, Stockfleth\u00a0E, Popp\u00a0G et\u00a0al (2009) Optimization of photodynamic therapy with a novel self-adhesive 5\u2011aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 160(5):1066\u20131074","journal-title":"Br J Dermatol"},{"issue":"4","key":"5682_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bjd.17435","volume":"180","author":"MV Heppt","year":"2019","unstructured":"Heppt\u00a0MV, Steeb\u00a0T, Ruzicka\u00a0T et\u00a0al (2019) Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis. Br J Dermatol 180(4):740\u2013748","journal-title":"Br J Dermatol"},{"key":"5682_CR13","unstructured":"https:\/\/www.bgbau.de\/themen\/sicherheit-und-gesundheit\/uv-strahlung-hitze, aufgerufen am 05.03.2026"},{"issue":"4","key":"5682_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/jdv.15422","volume":"33","author":"S Karrer","year":"2019","unstructured":"Karrer\u00a0S, Aschoff\u00a0RAG, Dominicus\u00a0R et\u00a0al (2019) Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany. J\u00a0Eur Acad Dermatol Venereol 33(4):661\u2013666","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"5682_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","volume":"78","author":"JYS Kim","year":"2018","unstructured":"Kim\u00a0JYS, Kozlow\u00a0JH, Mittal\u00a0B et\u00a0al (2018) Guidelines of care for the management of basal cell carcinoma. J\u00a0Am Acad Dermatol 78(3):540\u2013559","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"5682_CR16","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jdv.13228","volume":"29","author":"JP Lacour","year":"2015","unstructured":"Lacour\u00a0JP, Ulrich\u00a0C, Gilaberte\u00a0Y et\u00a0al (2015) Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J\u00a0Eur Acad Dermatol Venereol 29(12):2342\u20132348","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"5682_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1634\/theoncologist.2016-0186","volume":"21","author":"ME Lacouture","year":"2016","unstructured":"Lacouture\u00a0ME, Dr\u00e9no\u00a0B, Ascierto\u00a0PA et\u00a0al (2016) Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma. Oncologist 21(10):1218\u20131229","journal-title":"Oncologist"},{"key":"5682_CR18","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2022) Aktinische Keratose und Plattenepithelkarzinom der Haut, Langversion 2.0, 2022, AWMF-Registernummer: 032\/022OL. https:\/\/www.leitlinienprogrammonkologie.de\/leitlinien\/aktinische-keratosen-und-plattenepithelkarzinom-der-haut\/. Accessed 22.1.2026"},{"key":"5682_CR19","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2021) S3-Leitlinie Pr\u00e4vention von Hautkrebs, Langversion 2.1, 2021, AWMF Registernummer: 032\/052OL. https:\/\/www.leitlinienprogrammonkologie.de\/leitlinien\/hautkrebs-praevention\/. Accessed 22.1.2026"},{"issue":"1","key":"5682_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/01.coc.0000251224.16075.60","volume":"30","author":"WM Mendenhall","year":"2007","unstructured":"Mendenhall\u00a0WM, Amdur\u00a0RJ, Hinerman\u00a0RW et\u00a0al (2007) Skin cancer of the head and neck with perineural invasion. Am J Clin Oncol 30(1):93\u201396","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"5682_CR21","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/lary.20608","volume":"119","author":"WM Mendenhall","year":"2009","unstructured":"Mendenhall\u00a0WM, Amdur\u00a0RJ, Hinerman\u00a0RW et\u00a0al (2009) Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 119(10):1994\u20131999","journal-title":"Laryngoscope"},{"issue":"2","key":"5682_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","volume":"21","author":"MR Migden","year":"2020","unstructured":"Migden\u00a0MR, Khushalani\u00a0NI, Chang\u00a0ALS et\u00a0al (2020) Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol 21(2):294\u2013305","journal-title":"Lancet Oncol"},{"issue":"1","key":"5682_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1468-3083.2011.04005.x","volume":"26","author":"A Pflugfelder","year":"2012","unstructured":"Pflugfelder\u00a0A, Welter\u00a0AK, Leiter\u00a0U et\u00a0al (2012) Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3\u202f% diclofenac in 2.5\u202f% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. J\u00a0Eur Acad Dermatol Venereol 26(1):48\u201353","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"5682_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00105-021-04888-0","volume":"72","author":"U Reinhold","year":"2021","unstructured":"Reinhold\u00a0U, Bai-Habelski\u00a0J, Abeck\u00a0D et\u00a0al (2021) Kaliumhydroxid-5\u202f%-L\u00f6sung bei aktinischer Keratose : Ein neuer Therapieansatz zur l\u00e4sionsgerichteten Behandlung. Hautarzt 72(11):975\u2013983","journal-title":"Hautarzt"},{"issue":"8","key":"5682_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1056\/NEJMoa2502449","volume":"393","author":"D Rischin","year":"2025","unstructured":"Rischin\u00a0D, Porceddu\u00a0S, Day\u00a0F et\u00a0al (2025) Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma. N\u00a0Engl J Med 393(8):774\u2013785","journal-title":"N Engl J Med"},{"issue":"5","key":"5682_CR26","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/bjd.13138","volume":"171","author":"DM Rubel","year":"2014","unstructured":"Rubel\u00a0DM, Spelman\u00a0L, Murrell\u00a0DF et\u00a0al (2014) Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol 171(5):1164\u20131171","journal-title":"Br J Dermatol"},{"issue":"5","key":"5682_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.bjps.2019.09.022","volume":"73","author":"S Sepehripour","year":"2020","unstructured":"Sepehripour\u00a0S, Dawood\u00a0O, Hatter\u00a0S et\u00a0al (2020) An assessment of histological margins and recurrence of completely excised cutaneous SCC. J\u00a0Plast Reconstr Aesthet Surg 73(5):899\u2013903","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"6","key":"5682_CR28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","volume":"22","author":"AJ Stratigos","year":"2021","unstructured":"Stratigos\u00a0AJ, Sekulic\u00a0A, Peris\u00a0K et\u00a0al (2021) Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet Oncol 22(6):848\u2013857","journal-title":"Lancet Oncol"},{"key":"5682_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1110158","volume":"10","author":"C Symanzik","year":"2022","unstructured":"Symanzik\u00a0C, John\u00a0SM (2022) Sun protection and occupation: Current developments and perspectives for prevention of occupational skin cancer. Front Public Health 10:1110158","journal-title":"Front Public Health"},{"issue":"6","key":"5682_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.23736\/S0392-0488.18.06011-X","volume":"153","author":"RM Szeim\u00efes","year":"2018","unstructured":"Szeim\u00efes\u00a0RM (2018) Pain perception during photodynamic therapy: why is daylight PDT with methyl aminolevulinate almost pain-free? A review on the underlying mechanisms, clinical reflections and resulting opportunities. G\u00a0Ital Dermatol Venereol 153(6):793\u2013799","journal-title":"G Ital Dermatol Venereol"},{"key":"5682_CR31","doi-asserted-by":"crossref","unstructured":"Taccioli F, Blessent CGF, Paganelli A et\u00a0al. (2024) Delay in Cutaneous Squamous Cell Carcinoma Diagnosis Due to Interrupted Services Is Associated with Worse Prognoses and Modified Surgical Approaches. Cancers (Basel) 16(8)","DOI":"10.3390\/cancers16081469"},{"issue":"6","key":"5682_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00420-006-0155-y","volume":"80","author":"S Voelter-Mahlknecht","year":"2007","unstructured":"Voelter-Mahlknecht\u00a0S, Scheriau\u00a0R, Zwahr\u00a0G et\u00a0al (2007) Skin tumors among employees of a tar refinery: the current data and their implications. Int Arch Occup Environ Health 80(6):485\u2013495","journal-title":"Int Arch Occup Environ Health"},{"issue":"24","key":"5682_CR33","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1056\/NEJMra2206348","volume":"388","author":"A Wysong","year":"2023","unstructured":"Wysong\u00a0A (2023) Squamous-Cell Carcinoma of the Skin. N\u00a0Engl J Med 388(24):2262\u20132273","journal-title":"N Engl J Med"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05682-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05682-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05682-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:25:55Z","timestamp":1779798355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05682-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5682"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05682-6","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Drexler: Beraterhonorar, Reise\u2011\/Kongressunterst\u00fctzung, Honorare f\u00fcr Vortr\u00e4ge von BMS, MSD, Novartis, SunPharma und Pierre Fabre. A.\u00a0Bauer: Durchf\u00fchrung von klinischen Studien, Reise\u2011\/Kongressunterst\u00fctzung, Honorare f\u00fcr Vortr\u00e4ge\/Beratung und Forschungsf\u00f6rderung von AbbVie, Almirall, Amgen, AstraZeneca, BioCryst, Biofrontera, Blueberry Therapeutics, Celldex, Centogene, CSL Behring, Escient, Galderma, Genentech, Incyte, Jasper, KalVista, Leo, Lilly, L\u2019Oreal, Novartis, Otsuka, Pharvaris, Pierre Fabre, Regeneron, Sanofi, Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}